VIM
ABBV icon

Vinva Investment Management’s AbbVie ABBV Stock Holding History

Vinva Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130M Buy
511,672
+239,105
+88% +$51.4M 0.86% 21
2026
Q1 		$58.1M Buy
272,567
+32,537
+14% +$7.22M 0.72% 22
2025
Q4 		$55.1M Buy
240,030
+77,446
+48% +$17.6M 0.69% 24
2025
Q3 		$36.3M Buy
162,584
+31,451
+24% +$6.4M 0.71% 17
2025
Q2 		$23.9M Buy
131,133
+37,656
+40% +$7M 0.62% 30
2025
Q1 		$19.2M Buy
93,477
+1,344
+1% +$261K 0.76% 25
2024
Q4 		$16.2M Buy
92,133
+1,498
+2% +$275K 0.62% 30
2024
Q3 		$17.7M Buy
90,635
+9,937
+12% +$1.85M 0.75% 22
2024
Q2 		$13.6M Sell
80,698
-544
-0.7% -$90.1K 0.68% 21
2024
Q1 		$14.8M Buy
81,242
+2,729
+3% +$470K 0.83% 18
2023
Q4 		$12.1M Buy
78,513
+7,704
+11% +$1.12M 0.83% 21
2023
Q3 		$10.8M Buy
70,809
+17,752
+33% +$2.61M 1.01% 16
2023
Q2 		$7.07M Sell
53,057
-5,957
-10% -$874K 0.61% 35
2023
Q1 		$9.32M Buy
+59,014
New +$9.02M 0.78% 23

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vinva Investment Management's ABBV Position: Q2 2026 in Review

Vinva Investment Management increased its AbbVie (ABBV) stake by 88% in Q2 2026, buying an estimated $51.4M and bringing the position to 511,672 shares worth $130M. The position accounts for 0.86% of the portfolio, ranked #21.

Vinva Investment Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vinva Investment Management held 511,672 shares of AbbVie worth $130M as of Q2 2026.
  • Vinva Investment Management bought 239,105 AbbVie shares in Q2 2026, an estimated $51.4M.
  • AbbVie made up 0.86% of Vinva Investment Management's portfolio in Q2 2026, its #21 holding.
  • Vinva Investment Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.